Syndecan-1 as a new thrapeutic target in breast cancer
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/01/2009 - 31/12/2011
Description
Keywords: Mammakarzinom
Funder / funding scheme:
- Foundations / Trusts
Project management at the University of Münster
| Götte, Martin |
Applicants from the University of Münster
| Götte, Martin |
Publications of the University of Münster resulting from the project
Salem Gassar E, Ibrahim SA, Götte M (2011) In: Pavao MSG (eds.), Glycans in Diseases and Therapeutics, 139-158. Berlin Heidelberg: Springer VDI Verlag. doi:10.1007/978-3-642-16833-8 Research article (book contribution) | Peer reviewed | Published |
Doctorates resulting from the project
| Functional analysis of Syndecan-1, a novel target of miR-10b, in breast cancer progression Candidate: Abdel-Aziz Ibrahim, Sherif | Supervisors: Götte, Martin; Liebau, Eva; Greve, Burkhard Period of time: 05/01/2008 - 19/07/2011 Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster |
Habilitations resulting from the project
Role of the heparan sulfate proteoglycan Syndecan-1 as a modulator of inflammation and tumor progression Candidate: Götte, Martin | Reviewers: Kiesel, LudwigPeriod of time: 01/01/2008 - 12/04/2011 Habilitation procedure finished at: Habilitation procedure at University of Münster |